VOLUSON P8 ULTRASOUND SYSTEM

Device GE Healthcare
Total Payments
$25,693
Transactions
2
Doctors
0
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2019 $25,693 2 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $25,693 2 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
1) A METHOD TO ASSESS FETAL CARDIAC FUNCTION IN LABOR 2) THE EFFICACY OF USING THE ANGLE OF PROGRESSION (AOP) THROUGH TRANS- PERINEAL ULTRASOUND (TPU) TO PREDICT VAGINAL DELIVERY GE HEALTHCARE $19,903 0
1) A METHOD TO ASSESS FETAL CARDIAC FUNCTION IN LABOR 2) THE EFFICACY OF USING THE ANGLE OF PROGRESSION (AOP) THROUGH TRANS- PERINEAL ULTRASOUND (TPU) TO PREDICT VAGINAL DELIVERY GE Healthcare $5,790 0

Top Doctors Receiving Payments for VOLUSON P8 ULTRASOUND SYSTEM

Doctor Specialty Location Total Records
Unknown Denver, CO $25,693 2

About VOLUSON P8 ULTRASOUND SYSTEM

VOLUSON P8 ULTRASOUND SYSTEM is a device associated with $25,693 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is GE Healthcare.

Payment data is available from 2019 to 2019. In 2019, $25,693 was paid across 2 transactions to 0 doctors.

The most common payment nature for VOLUSON P8 ULTRASOUND SYSTEM is "Unspecified" ($25,693, 100.0% of total).

VOLUSON P8 ULTRASOUND SYSTEM is associated with 2 research studies, including "1) A METHOD TO ASSESS FETAL CARDIAC FUNCTION IN LABOR 2) THE EFFICACY OF USING THE ANGLE OF PROGRESSION (AOP) THROUGH TRANS- PERINEAL ULTRASOUND (TPU) TO PREDICT VAGINAL DELIVERY" ($19,903).